Clinical study treating BPDCN with tagraxofusp led to first FDA approval for the disease.
/Film is Going Dark Today Because Black Lives Matter – Here Are Some Organizations and Causes That Need Your Help
Targeted therapy proves effective against aggressive rare blood cancer
Clinical study treating BPDCN with tagraxofusp led to first FDA approval for the disease.
No Comment